Warning: The NCBI web site requires JavaScript to function. more...
A Framework for Decision-Making for Mass Distribution of Mectizan(R) in Areas Endemic for Loa loa.
Addiss DG, Rheingans R, Twum-Danso NA, Richards FO.
Filaria J. 2003 Oct 24;2 Suppl 1:S9.
Related citations
Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P.
Filaria J. 2005 Apr 7;4(1):2.
Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.
Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas.
Filaria J. 2003 Oct 24;2 Suppl 1:S2.
The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA).
Zouré HG, Wanji S, Noma M, Amazigo UV, Diggle PJ, Tekle AH, Remme JH.
PLoS Negl Trop Dis. 2011 Jun;5(6):e1210. Epub 2011 Jun 28.
Validation of the Rapid Assessment Procedure for Loiasis (RAPLOA) in the Democratic Republic of Congo.
Wanji S, Akotshi DO, Mutro MN, Floribert T, Ukety TO, Diggle PJ, Remme JH.
Parasit Vectors. 2012 Feb 2;5(1):25. [Epub ahead of print]
Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
Tekle AH, Zoure H, Wanji S, Leak S, Noma M, Remme JH, Amazigo U.
Acta Trop. 2011 Sep;120 Suppl 1:S81-90. Epub 2010 Jun 4.
Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP.
Am J Trop Med Hyg. 1998 Apr;58(4):461-9.
Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
Pion SD, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.
Parasitology. 2006 Jul;133(Pt 1):101-9.
Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.
Boussinesq M, Gardon J.
Ann Trop Med Parasitol. 1997 Sep;91(6):573-89. Review.
Prevalences of loiasis in Ondo state, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA).
Adeoye GO, Akinsanya B, Otubanjo AO, Ibidapo CA, Atalabi T, Okwuzu J, Adejai EO, Braide EI.
Ann Trop Med Parasitol. 2008 Apr;102(3):215-27.
The Mectizan Donation Program (MDP).
Thylefors B.
Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:39-44.
Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future.
Twum-Danso NA.
Filaria J. 2003 Oct 24;2 Suppl 1:S7.
Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
Pion DS, Gardon J, Kamgno J, Gardon-Wendel N, Chippaux JP, Boussinesq M.
Parasitology. 2004 Nov;129(Pt 5):613-26.
Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
Esum M, Wanji S, Tendongfor N, Enyong P.
Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):673-6.
Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon.
Wanji S, Tendongfor N, Esum M, Ndindeng S, Enyong P.
Med Microbiol Immunol. 2003 Feb;192(1):15-21. Epub 2003 Jan 24.
Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Thomson MC, Obsomer V, Dunne M, Connor SJ, Molyneux DH.
Lancet. 2000 Sep 23;356(9235):1077-8. Erratum in: Lancet 2000 Sep 30;356(9236):1198.
Rapid assessment method for prevalence and intensity of Loa loa infection.
Takougang I, Meremikwu M, Wandji S, Yenshu EV, Aripko B, Lamlenn SB, Eka BL, Enyong P, Meli J, Kale O, Remme JH.
Bull World Health Organ. 2002;80(11):852-8. Epub 2002 Dec 3.
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.
Haselow NJ, Akame J, Evini C, Akongo S.
Filaria J. 2003 Oct 24;2 Suppl 1:S10.
Filaria control and elimination: diagnostic, monitoring and surveillance needs.
Molyneux DH.
Trans R Soc Trop Med Hyg. 2009 Apr;103(4):338-41. Epub 2009 Jan 31.
Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
Twum-Danso NA, Meredith SE.
Trop Med Int Health. 2003 Sep;8(9):820-31.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on